More women will get shorter courses of nitrofurantoin for uncomplicated bladder infections

January 2008

More women will get shorter courses of nitrofurantoin for uncomplicated bladder infections.

These infections are usually treated with TMP/SMX or a quinolone for 3 days...or nitrofurantoin for 7 days.

Now evidence suggests that nitrofurantoin for just 5 days works as well as TMP/SMX for 3 days for uncomplicated cystitis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

The DEA now allows prescribers to write multiple C-II Rxs on the same day, for the same patient and drug
Cardiology whether a beta-blocker should be started before noncardiac surgery
Psychiatry Abilify (aripiprazole) is the first antipsychotic approved for major depressive disorder
Neurology & Pain Voltaren Gel and Flector Patch will be the first TOPICAL Rx NSAIDs to be commercially available for pain
Diabetes The new Symlin (pramlintide) pen will help reduce errors
Alcohol whether they can drink alcohol with their medications
Women's Health More women will get shorter courses of nitrofurantoin for uncomplicated bladder infections
Renal & Urology Sanctura XR, a new long-acting formulation of trospium for overactive bladder
Respiratory & Allergy Many patients are getting both Spiriva and ipratropium together
Respiratory & Allergy Cetirizine (Zyrtec, Zyrtec-D) will soon be available OTC
Respiratory & Allergy alternatives to traditional OTC cough and cold medicines for infants and young children
Diabetes & Endocrinology Desmopressin nasal sprays (DDAVP, Stimate, etc) are no longer approved for bedwetting
Vaccines New rules will help clarify Medicare Part D billing for Zostavax (zoster vaccine)